Dual engineered gold nanoparticle based synergistic prophylaxis delivery system for HIV/AIDS

Area of Science:

• Biotechnology and Nanomedicine
• Immunology
• Virology

Background:

• Human immunodeficiency virus (HIV) remains a global pandemic, necessitating improved treatment strategies.
• Current antiretroviral therapies, while effective, are associated with significant long-term side effects.
• Nanomaterials, particularly gold nanoparticles (AuNPs), show promise for targeted drug delivery due to their biocompatibility.

Purpose of the Study:

• To explore the potential of gold nanoparticles (AuNPs) as a drug delivery system for HIV treatment.
• To hypothesize a combination drug delivery strategy using AuNPs to overcome limitations of existing antiretroviral therapies.
• To investigate the immune effects and safety profile of AuNPs in the context of HIV therapy.

Main Methods:

• Review of current advancements in biotechnology and nanomaterial applications for drug delivery.
• Hypothetical model proposing combination antiretroviral drug delivery using gold nanoparticles.
• Analysis of AuNP interaction with viral components like gp120 and host cells like CD4 T cells.

Main Results:

• Gold nanoparticles (AuNPs) demonstrate potential as biocompatible excipients for enhanced drug delivery.
• A combination strategy using AuNPs could mitigate adverse effects associated with conventional antiretroviral drugs.
• AuNPs may facilitate targeted delivery to inhibit viral entry by binding to gp120 and preventing CD4 T cell interaction.

Conclusions:

• Gold nanoparticle-based combination drug delivery presents a promising strategy for more effective and safer HIV treatment.
• This approach could suppress viral replication and target key viral entry mechanisms.
• Further development of AuNP-based therapies holds potential for reducing toxicity and improving patient outcomes in HIV management.